Stifel Nicolaus Downgrades Auxilium Pharmaceuticals To Hold, Shares Drop

Analysts at Stifel Nicolaus downgraded Auxilium Pharmaceuticals AUXL from Buy to Hold and removed the price target of $30.00. Auxilium Pharmaceuticals shares have surged 65.64% over the past 52 weeks, while the S&P 500 index has gained 18.13% in the same period. Auxilium Pharmaceuticals' shares dropped 1.41% to $30.70 in pre-market trading.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: DowngradesAnalyst RatingsStifel Nicolaus
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!